Collegium Pharmaceutical, Inc. (FRA:354)

Collegium Pharmaceutical Revenue

Collegium Pharmaceutical had revenue of $209.36M USD in the quarter ending September 30, 2025, with 31.42% growth. This brings the company's revenue in the last twelve months to $757.07M, up 26.34% year-over-year. In the year 2024, Collegium Pharmaceutical had annual revenue of $631.45M with 11.41% growth.

• Revenue (ttm): $757.07M
• Revenue Growth: +26.34%
• P/S Ratio: 1.97
• Revenue / Employee: $2.12M
• Employees: 357
• Market Cap: 1.27B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	631.45M	64.68M	11.41%
Dec 31, 2023	566.77M	102.83M	22.17%
Dec 31, 2022	463.93M	187.07M	67.56%
Dec 31, 2021	276.87M	-33.15M	-10.69%
Dec 31, 2020	310.02M	13.32M	4.49%
Dec 31, 2019	296.70M	16.29M	5.81%
Dec 31, 2018	280.41M	251.94M	884.73%
Dec 31, 2017	28.48M	26.77M	1,564.29%
Dec 31, 2016	1.71M	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-